Previous work has shown a reduction in cephaloridine nephrotoxicity in a diabetic rat model. The following studies examined in vitro cephaloridine toxicity in renal slices from normoglycemic and diabetic Fischer 344 rats. Diabetes was induced by acute intraperitoneal injection of 35 mg/kg streptozotocin. Renal cortical slices were isolated from normoglycemic and diabetic animals. Tissues were exposed to 0-5 mM cephaloridine for 15-120 min. Pyruvate-directed gluconeogenesis was diminished in all groups exposed to 2-5 mM cephaloridine for 60-120 min. Leakage of lactate dehydrogenase (LDH) was apparent only in the normoglycemic group in the presence of 4-5 mM cephaloridine for 120 min. LDH leakage was not increased at any cephaloridine concentration in the diabetic tissue. Total glutathione levels were compared in renal cortical slices exposed to cephaloridine for 30-120 min. Baseline values for glutathione were comparable between normoglycemic and diabetic tissue suggesting that the mechanism for reduced toxicity was not due to higher glutathione levels in diabetic tissue. Total glutathione levels were diminished more rapidly in normoglycemic than diabetic tissue by incubation with 5 mM cephaloridine. Comparison of cephaloridine accumulation indicated that diabetic tissue accumulated less cephaloridine than the normoglycemic group when tissues were incubated with 0-2 mM cephaloridine. However, renal slice accumulation was similar between normoglycemic and diabetic groups following in vitro incubation with 4-5 mM cephaloridine. These results suggest that the mechanism for reduced in vitro cephaloridine toxicity in diabetic tissue cannot be limited to differences in accumulation and must include an unidentified cellular component, e 1997 society of Toxicology.
Cephaloridine, a cephalosporin antibiotic, is associated with nephrotoxicity in humans (Kabins and Cohen, 1966; Foord, 1975) as well as experimental animals (Atkinson et al., 1966) . The antibiotic was withdrawn from clinical use following several reports of renal damage in patients treated with high doses of cephaloridine. Although cephaloridine is no longer approved for clinical application, cephaloridine continues to be an important investigative tool since the primary target of this antibiotic is the S 2 and S 3 segment of the proximal tubule (Silverblatt et al., 1970; Cojocel et al., 1983) . Cellular changes associated with cephaloridine include rapid loss of the brush border, increased vacuole formation, and rounding of mitochondria.
The selectivity of cephaloridine for the proximal tubule may be due to the chemical properties of the antibiotic. Cephaloridine attains very high intracellular levels within the proximal tubule because it is actively transported into the cell along the basolateral membrane by the anion transporter but efflux out of the cell along the brush border is very slow since cephaloridine exists as a zwitterion (Welles et al., 1966; Tune, 1972; Tune et al, 1974) . As a result of this phenomenon, cephaloridine selectively accumulates in the cortex to concentrations that are much higher than plasma levels (Tune and Fravert, 1980) . Consequently, intracellular organelles within the proximal tubule are exposed to higher levels of cephaloridine than other tissues.
Although the exact mechanism of cephaloridine toxicity has not been identified, mitochondrial damage and/or acylation of mitochondrial proteins have been proposed as possible cellular mechanisms of toxicity. Renal cortical mitochondrial function is rapidly diminished by cephaloridine (Tune et al., 1979) . The diminished mitochondrial respiration induced by cephaloridine has been suggested to be mediated by acylation of substrate transporters and subsequent reduction of substrate supply to the mitochondria (Tune et al., 1988) . Toxicity may also be due to oxidative stress through generation of peroxidative species (Kuo et al., 1983; Cojocel et al., 1985) . Kuo and associates (1983) reported a rapid depletion of glutathione and increased lipid peroxide formation in Fischer 344 rats following cephaloridine administration. Cephaloridine was also capable of inducing lipid peroxidation directly in renal microsomes (Cojocel et al., 1985) and in renal slices (Goldstein et al., 1986) .
Toxicity is apparent following acute administration in vivo as well as in vitro following cephaloridine exposure of renal slices or tubules. Renal cortical slices exhibit a concentration-and time-dependent decrease in gluconeogenesis and diminished accumulation of organic ions (Goldstein et ai, 1986) . Diminished sodium-potassium ATPase activity and mitochondrial function are also evident in primary cultures of rat renal cortical epithelial cells exposed to cephaloridine (Smith and Acosta, 1987) . Cephaloridine toxicity is apparent in species other than rats. For example, isolated rabbit proximal tubules (Rush and Ponsler, 1991) exposed to cephaloridine experience a rapid decline in mitochondrial function and depletion of ATP. Cephaloridine can also mediate a rapid depletion of glutathione and induction of lipid peroxidation (Rush and Ponsler, 1990) prior to induction of cell leakage of lactate dehydrogenase (LDH). Earlier studies (Valentovic et ai, 1989) observed that cephaloridine in vivo nephrotoxicity was diminished in streptozotocin (STZ) diabetic Fischer 344 rats. Acute administration of cephaloridine in normoglycemic rats was associated with increased kidney weight, elevated blood urea nitrogen concentration, and diminished renal cortical slice accumulation of organic ions. Diabetic animals, however, exhibited comparable values for blood urea nitrogen concentration and renal cortical slice accumulation of organic anions between pair-fed controls and cephaloridine-treated animals. Therefore, preliminary studies established that the streptozotocin diabetic rat is a model that is less susceptible to cephaloridine toxicity. Later studies have determined that regulation of the diabetic state by insulin pretreatment reversed the protection associated with the diabetic state (Valentovic and Ball, 1995) . These results support the hypothesis that resistance was conferred by the diabetic state and not streptozotocin. The potential significance of this observation is that understanding the mechanism for reduced toxicity may provide new avenues to avert the renal damage of other compounds that induce oxidative stress or alter mitochondrial function.
The following were the aims of this paper: (a) compare in vitro cephaloridine toxicity between diabetic and normoglycemic animals; (b) determine the contribution of renal accumulation to reduced toxicity in diabetic tissue; and (c) examine whether diabetic tissue is resistant to toxicity due to a higher glutathione status. In vitro exposure obviated differences in toxicity due to physiological changes in glomerular filtration rate or renal blood flow that are known to occur in diabetes. Renal cortical slices were selected as the in vitro model for all studies. Although the mechanism for reduced toxicity has not been entirely established, the mechanism may be a combination of alterations in renal accumulation and/or cellular changes that protect the diabetic tissue from toxicity. Understanding the mechanism for reduced cephaloridine toxicity in diabetes may provide new information that could have more general applicability in developing new interventions of other nephrotoxic agents.
METHODS
Chemicals. Cephaloridine, glucose oxidase and LDH activity kits, reduced glutathione, and NADPH were purchased from Sigma Chemical Co. (St. Louis, MO.). All buffer components were obtained from Fisher Scientific (Pittsburgh, PA) and the reagents for glutathione determination were from Aldrich Chemical Co. (Milwaukee, WT).
Animals. Male Fischer 344 rats (180-220 g) were purchased from Hilltop Lab Animals, Inc. (Scottsdale, PA). The animals were maintained under a controlled ambient temperature (21-23°C) and light cycle (lights on 0600-1800 hr). The animals were provided standard Punna Rat Chow and water ad libitum. All rats were given a minimum 5-day acclimation period prior to initiation of any experiments.
Induction of diabetes. Animals were injected (intraperitoneally) with 35 mg/kg streptozotocin freshly prepared in citrate-phosphate buffer at pH 4.6. The composition of the citrate buffer was as follows: 53 mM citric acid monhydrate and 92 mM disodium phosphate anhydrous. Diabetes was confirmed by glucosuria in excess of 100 mg/dl using Diastix. Experiments were conducted 7 days after injection of streptozotocin.
Incubation of renal slices. Rats were anesthetized with diethyl ether and the kidneys were excised, decapsulated, cut longitudinal and latitudinal, and placed in 5-ml ice-cold Krebs-Ringer buffer. The composition of the buffer was as follows (in mM); 126.4 NaCl; 6.0 Na 2 HPO 4 ; 5.2 KC1; 1.3 MgSO 4 ; and 1.3 CaCl 2 . Renal cortical slices were prepared as described previously (Valentovic et al., 1992a,b) . Briefly, the cortex of the quartered kidney was sliced freehand and added to 5 ml Krebs-Ringer solution. The tissues were washed by incubating the slices for 3 min m 5 ml oxygenated Krebs-Ringer buffer at 25°C under an oxygen atmosphere and constant shaking (100 cycles/min) in a Dubnoff metabolic incubator. At the end of the 3-min period, excess buffer was blotted and the tissue was placed in 5 ml fresh oxygenated Krebs-Ringer buffer and incubated for 3 min; the tissue was washed a total of three times. Upon completion of the wash period, the slices (70-100 mg) were added to 1.5 ml oxygenated KrebsRinger buffer and allowed to equilibrate for 5 min at 37°C under an oxygen atmosphere and constant shaking (100 cycles/min). Cephaloridine was added in 1.5 ml oxygenated Krebs-Ringer to yield a total bath volume of 3 ml and a final cephalondine concentration of 0, 2, 4, or 5 mM. The tissues were incubated for 90 min with the designated concentration of cephaloridine. At the end of this time period, a 100-/il aliquot of pyruvate (final concentration 10 mM) was added to stimulate gluconeogenesis and the tissues were incubated another 30 min. At the end of the incubation period, the tissue was blotted of excess medium and weighed. The medium was decanted, placed on ice, and centrifuged at 2000g for 10 min at 4°C. The medium was stored at 4°C prior to determination of glucose concentration and LDH activity. The criterion for viability of slices was data from an animal was discarded if control LDH values exceeded 10% of total or glucose formation was less than 1.5 mg/g tissue.
Other studies examined LDH leakage and pyruvate-directed gluconeogenesis as a function of time. Renal cortical slices derived from normoglycemic and diabetic animals were incubated with 0 or 4 mM cephaloridine for 15, 30, 60, 90, or 120 min in the presence of 10 mM pyruvate. LDH leakage was expressed as a percentage of total and glucose formation was expressed as milligram per gram of tissue.
LDH leakage and gluconeogenesis.
An aliquot of medium was used for determination of LDH leakage. LDH release was expressed as a percentage of total where total LDH release was the sum of LDH remaining in the tissue and LDH released into the medium. LDH was released from tissue by a 30-min incubation of tissue in a 10% Triton X-100 solution. LDH release was quantitated using a spectrophotometric kinetic assay (Sigma, Kit No. 228) . Glucose formation was quantitated using a glucose oxidase enzymatic procedure (Sigma, Kit No. 510) . Glucose formation was expressed as milligrams glucose/gram tissue.
Renal cephaloridine accumulation.
Experiments were performed to test the hypothesis that in vitro toxicity was diminished in diabetic tissue because of decreased cephaloridine accumulation. These studies were conducted using renal cortical slices in order to remove the confounding factors of physiological changes in renal blood flow and glomerular filtration rate that occur in diabetes. Renal cortical slices from normoglycemic and diabetic animals were incubated for 30 min at 37°C under an oxygen atmosphere and constant shaking (100 cycles/min) with 0-5 mM cephaloridine in a total volume of 3 ml Krebs buffer. The renal cortical slices were removed from the medium weighed and homogenized in water (5 vol/ weight) using a Tekmar homogenizer (Cincinnati, OH). All tissues were homogenized on ice. Cephaloridine was measured using an HPLC method (Pasino et al., 1985) . A 300-/xl aliquot of renal homogenate was added to 700 /il acetonitrile in order to precipitate the proteins. A Beckman (Columbia, MD) HPLC system with an 1SCO variable wavelength detector was used for all analyses. Cephaloridine was quantitated at a wavelength of 254 nm using a Waters C18 /jBondapak column. The mobile phase was 20% acetonitrile prepared in 1% acetic acid at a flow rate of 1.5 ml/min. The extraction efficiency was greater than 96%.
Determination of glutathione. Total and oxidized glutathione were measured in renal cortical slices incubated with 0 or 5 mM cephaloridine for 15, 30, 60, or 120 min. Renal cortical slices were blotted, weighed, and homogenized in 5% sulfosalicylic acid using a Tekmar homogenizer. The homogenizer probe was rinsed with 500 /i\ sulfosalicylic acid and a final volume of 1 ml. The homogenate was centrifuged at 10,0O0g for 10 min at 4°C. Total glutathione was measured according to the procedures described by Griffith (1980) . Glutathione levels were expressed as nmoles per gram of tissue.
Statistical analysis. Values were reported as means ± SE with all groups containing a minimum of five different animals. Differences within groups were quantitated using an analysis of variance (ANOVA) followed by a Dunnett's at a 95% confidence interval. Differences between groups were determined using a one way analysis of variance followed by a Newman Keuls if multiple groups were present.
RESULTS

Diabetic Status of the Animals
Diabetes was confirmed in the diabetic animals by glucosuria in excess of 200 mg/dl. Plasma glucose values were 145 ± 10 mg/dl in the normoglycemic group compared to 486 ± 32 mg/dl in the diabetic group.
Concentration and Time-Dependent Toxicity
Cephaloridine inhibited pyruvate directed gluconeogenesis in normoglycemic and diabetic tissue. Incubation of renal slices with 2-5 mM cephaloridine produced a concentrationdependent inhibition of gluconeogenesis (Fig. 1) , when compared to control, in normoglycemic and diabetic tissue. Cephaloridine induced a rise in LDH leakage only in the normoglycemic group (Fig. 2) . A cephaloridine concentration of 4-5 mM was needed to induce LDH leakage relative to vehicle treated tissue. LDH leakage was not elevated in diabetic tissue exposed to 2-5 mM cephaloridine for 120 min. The results indicate cephaloridine toxicity was greater in the normoglycemic than the diabetic group. These results are also in agreement with previous in vivo findings of decreased susceptibility in diabetic groups toward cephaloridine toxicity.
Studies were next conducted to investigate whether the diabetic state delayed the appearance of cephaloridine cyto- toxicity. Toxicity was assessed as a function of time in tissues exposed to 4 mM cephaloridine, a concentration sufficient to elevated LDH leakage in the normoglycemic group. Comparisons of control and cephaloridine-treated slices within the normoglycemic group, indicated that differences in pyruvate directed glucose formation occurred prior to elevations in LDH leakage. Cephaloridine decreased pyruvatedirected gluconeogenesis (Fig. 3 ) when compared to vehicle treated tissue within 60 min in renal slices from normoglycemic and diabetic animals. LDH leakage was increased following a 120 min exposure to 4 mM cephaloridine in the normoglycemic tissue (Table 1) . No difference in LDH leakage was determined between control and cephaloridineexposed renal slices obtained from diabetic animals. These results suggest that cephaloridine produced a time-dependent change in gluconeogenesis in normoglycemic and diabetic tissue. However, the diabetic group was less susceptible to cephaloridine toxicity since LDH leakage was not elevated above control values in renal slices from diabetic rats.
Glutathione Status
Comparison of control values indicated that total glutathione levels were comparable between normoglycemic and 
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T mulation were not apparent between normoglycemic and diabetic groups when the concentration of cephaloridine was increased to 4 and 5 mM. These results suggest that accumulation was not the primary mechanism for attenuation of toxicity since accumulation differences between normoglycemic and diabetics were not evident at 4-5 mM cephaloridine, a concentration that induced LDH leakage in renal slices from normoglycemic animals.
DISCUSSION
Cephaloridine in vitro toxicity was diminished in diabetic relative to normoglycemic tissue. The diabetic group exhibited decreased renal toxicity when comparisons were made as a function of concentration or time of exposure to cephaloridine. These findings were in agreement with in vivo studies (Valentovic et al., 1989 ) that had characterized a resistance in diabetic animals injected with a toxic dose of cephaloridine. Additional studies later established that the resistance toward cephaloridine in vivo toxicity was revers-
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FIG. 2. Concentration-dependent effect of cephaloridine on LDH leakage. Renal cortical slices were incubated with 0-5 nun cephaloridine for 120 nun. LDH leakage was expressed as a percentage of total. Values represent means ± SE with four to six animals/group. *Different (p < 0.05) from respective control (0 mM). diabetic tissue (Table 2) . These findings would suggest that the reduced susceptibility in the diabetic model was not due to a higher baseline level of glutathione protecting the diabetic tissue from oxidative stress. Cephaloridine addition to renal slices from normoglycemic animals decreased (p < 0.05) total glutathione levels within 60 min when compared to control values. Cephaloridine addition to the diabetic tissue required an exposure time of 120 min to decrease total glutathione levels relative to control values. The data obtained on glutathione levels indicated that the diabetic group was less susceptible to depletion of glutathione by cephaloridine. Oxidized glutathione levels were not reported as the levels approached the sensitivity of the assay.
Cephaloridine Accumulation
Diminished cephaloridine accumulation would be a plausible explanation for the disparity in toxicity between normoglycemic and diabetic tissue. Renal cortical slice accumulation of cephaloridine was increased as a function of concentration in normoglycemic and diabetic tissues (Fig. 4) . Cephaloridine accumulation was lower in the diabetic compared to the normoglycemic tissue when renal slices were incubated with =s2 mM cephaloridine. Differences in accu-I. ible when diabetic rats were pretreated with insulin prior to glycemic and diabetic animals. However, urinary cephaloricephaloridine administration (Valentovic and Ball, 1995) .
dine excretion was higher in diabetic compared to normoglyNumerous physiological and biochemical changes occur in cemic rats. These studies also showed that renal cephaloridine the kidney of diabetic animals and humans. Streptozotocin levels that were toxic in the normoglycemic animals were not diabetic animals rapidly develop an increase in renal blood toxic in the diabetic group. Further studies presented in the flow and glomerular filtration rate (Jensen et al., 1981; Evan current paper confirm that cephaloridine accumulation in renal et al., 1984) . The increased glomerular filtration rate would be slices was lower at minimally toxic doses but concentrations expected to enhance renal excretion of a compound excreted that induce LDH leakage in the normoglycemic group were primarily by filtration with minimal lumenal reabsorption. not capable of increasing LDH leakage in the diabetic group. Conversely, the potential for toxicity could be enhanced if These findings also support the notion that toxicity can be the development of toxicity was dependent on lumenal expo-reduced independent of renal physiological changes associsure to an individual toxicant. Previously published studies ated with diabetes mellitus. (Valentovic et al., 1996) had reported that renal cephaloridine Reduced renal slice accumulation was a possible explanalevels were lower in the diabetic relative to normoglycemic tion for the inability of cephaloridine to directly induce LDH rat and that cephaloridine was more rapidly removed from leakage in vitro in the diabetic group. The accumulation the kidney in diabetic compared to normoglycemic rats fol-studies indicated that diabetic tissue had lower cephaloridine lowing a single (intraperitoneal) injection. Two potential ex-levels at sublethal drug concentrations. However, cephaloriplanations for this observation were either decreased cephalor-dine accumulation in renal slices was comparable between idine uptake into the kidney or enhanced renal excretion, normoglycemic and diabetic tissue when the cephaloridine Diminished renal uptake did not seem to be the mechanism level was elevated to 4-5 mM, a concentration sufficient to as plasma cephaloridine levels were similar between normo-induce LDH leakage in the normoglycemic but not diabetic renal slices. These findings would suggest that diminished accumulation was only part of the mechanism for reduced in vitro toxicity and that other factors must be involved.
The diabetic condition is associated with numerous intracellular changes that may influence the response of an individual cell to a toxin. The diabetic kidney has higher rates of RNA synthesis and an increased uracil ribonucleotide pool (Cortes et al., 1987) . Other changes that occur in the kidney include altered expression of sodium-glucose cotransporters within the proximal tubule (Dominguez et al., 1994) and enhanced calcium-magnesium ATPase activity (Levy et al., 1986) .
Very little information is known regarding the ability of the diabetic kidney to handle oxidative stress. Measurement of total glutathione levels in renal slices following direct exposure to cephaloridine indicated that the diabetic tissue was more resistant to depletion of glutathione when compared to normoglycemic tissue. These results indicated that renal cortical slices from diabetic rats do not have higher baseline values for glutathione. Based on these findings, it is possible that the attenuation in renal cephaloridine damage in diabetes may be due to an enhanced ability to protect against peroxidative damage. It has yet to be resolved whether glutathione reductase is enhanced in the streptozotocin model. Further studies also need to address whether the level of NADPH is higher in diabetes and what is the role of NADPH in maintaining glutathione in its reduced state. Studies conducted by other investigators using a different strain of rodent and another model of chemical induced diabetes have examined the capacity of the diabetic kidney to handle peroxidative damage. Asayama and associates (1989) reported that cytochrome c and glutathione peroxidase activity are elevated in whole kidney homogenates from Sprague-Dawley rats 14 days after streptozotocin injection. Studies conducted with alloxan-mediated diabetic SpragueDawley rats showed that renal tissue was more resistant to peroxidative damage by a ferrous/ascorbate free radical generating system (Parinandi et al., 1990) .
In summary, cephaloridine in vitro toxicity was reduced in renal slices from diabetic Fischer 344 rats relative to normoglycemic tissue. Renal slice accumulation of cephaloridine was lower in the diabetic group at cephaloridine concentrations that produced minimal toxicity. No difference in renal slice accumulation was apparent when the cephaloridine concentration was elevated to 4-5 mM, a concentration sufficient to induce LDH leakage only in the normoglycemic group. Total glutathione levels were more rapidly diminished in the normoglycemic tissue when compared to the diabetic group. These findings support the conclusion that diminished renal accumulation is only part of the mechanism for reduced toxicity and that an unidentified cellular difference is also part of the mechanism for reduced toxicity in streptozotocin diabetic rats.
